Comparison of high-flow nasal cannula and conventional nasal cannula during sedation for endoscopic submucosal dissection: a retrospective study.

Seungwon Lee, Ji Won Choi, In Sun Chung, Duk Kyung Kim, Woo Seog Sim, Tae Jun Kim
{"title":"Comparison of high-flow nasal cannula and conventional nasal cannula during sedation for endoscopic submucosal dissection: a retrospective study.","authors":"Seungwon Lee,&nbsp;Ji Won Choi,&nbsp;In Sun Chung,&nbsp;Duk Kyung Kim,&nbsp;Woo Seog Sim,&nbsp;Tae Jun Kim","doi":"10.1177/17562848231189957","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The high-flow nasal cannula (HFNC) is a relatively recent method that provides high-flow, heated, humidified gas delivery.</p><p><strong>Objectives: </strong>We compared HFNC (group HF) and conventional nasal cannula (NC) (group CO) during deep sedation with propofol and remifentanil for endoscopic submucosal dissection (ESD).</p><p><strong>Design: </strong>Single-center, retrospective observational cohort study.</p><p><strong>Methods: </strong>In this study, a total of 159 cases were analyzed (group CO, 71 and group HF, 88). We collected the data from electronic medical records from September 2020 to June 2021. The lowest oxygen saturation (SpO<sub>2</sub>), incidence of hypoxia (SpO<sub>2</sub> < 90%), rescue interventions, and adverse events between the two groups were investigated.</p><p><strong>Results: </strong>There were significant differences between the two groups in lowest SpO<sub>2</sub> and incidence of hypoxia [group CO <i>versus</i> group HF; 90.3 ± 9.7% <i>versus</i> 95.7 ± 9.0%, 25 (35.2%) <i>versus</i> 10 (11.4%); <i>p</i> < 0.001, <i>p</i> < 0.001; respectively]. Among the rescue interventions, the number of jaw thrust, patient stimulation, O<sub>2</sub> flow increase, and nasal airway insertion were significantly higher in the CO group than in the HF group. However, postprocedural chest X-ray showed higher rates of abnormal findings (atelectasis, aspiration, and pneumoperitoneum) in group HF than in group CO [group CO: 8 (11.3%) <i>versus</i> group HF: 26 (29.5%), <i>p</i> = 0.005]. In multivariable analysis, besides group CO, difficult type of lesion was the risk factor for hypoxia.</p><p><strong>Conclusions: </strong>Compared to the conventional NC, HFNC provided adequate oxygenation and a stable procedure without significant adverse events during sedation for ESD. However, caution is needed to avoid complications associated with deep sedation and difficult type of lesions.</p>","PeriodicalId":23022,"journal":{"name":"Therapeutic Advances in Gastroenterology","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/c9/10.1177_17562848231189957.PMC10467296.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562848231189957","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The high-flow nasal cannula (HFNC) is a relatively recent method that provides high-flow, heated, humidified gas delivery.

Objectives: We compared HFNC (group HF) and conventional nasal cannula (NC) (group CO) during deep sedation with propofol and remifentanil for endoscopic submucosal dissection (ESD).

Design: Single-center, retrospective observational cohort study.

Methods: In this study, a total of 159 cases were analyzed (group CO, 71 and group HF, 88). We collected the data from electronic medical records from September 2020 to June 2021. The lowest oxygen saturation (SpO2), incidence of hypoxia (SpO2 < 90%), rescue interventions, and adverse events between the two groups were investigated.

Results: There were significant differences between the two groups in lowest SpO2 and incidence of hypoxia [group CO versus group HF; 90.3 ± 9.7% versus 95.7 ± 9.0%, 25 (35.2%) versus 10 (11.4%); p < 0.001, p < 0.001; respectively]. Among the rescue interventions, the number of jaw thrust, patient stimulation, O2 flow increase, and nasal airway insertion were significantly higher in the CO group than in the HF group. However, postprocedural chest X-ray showed higher rates of abnormal findings (atelectasis, aspiration, and pneumoperitoneum) in group HF than in group CO [group CO: 8 (11.3%) versus group HF: 26 (29.5%), p = 0.005]. In multivariable analysis, besides group CO, difficult type of lesion was the risk factor for hypoxia.

Conclusions: Compared to the conventional NC, HFNC provided adequate oxygenation and a stable procedure without significant adverse events during sedation for ESD. However, caution is needed to avoid complications associated with deep sedation and difficult type of lesions.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高流量鼻插管与常规鼻插管在内镜下粘膜下剥离术中镇静的比较:回顾性研究。
背景:高流量鼻插管(HFNC)是一种相对较新的方法,提供高流量,加热,加湿的气体输送。目的:比较HFNC (HF组)和常规鼻插管(NC) (CO组)在异丙酚和瑞芬太尼深度镇静下进行内镜下粘膜剥离(ESD)的效果。设计:单中心、回顾性观察队列研究。方法:本研究共对159例患者进行分析,其中CO组71例,HF组88例。我们收集了2020年9月至2021年6月的电子病历数据。最低血氧饱和度(SpO2)、缺氧发生率(SpO2)结果:两组患者最低血氧饱和度(SpO2)及缺氧发生率差异均有统计学意义[CO组与HF组;90.3±9.7%和95.7±9.0%,25(35.2%)和10 (11.4%);CO组p p 2流量增加,鼻导气管插入量明显高于HF组。然而,术后胸部x线显示,HF组的异常表现(肺不张、误吸和气腹)发生率高于CO组[CO组:8 (11.3%)vs HF组:26 (29.5%),p = 0.005]。在多变量分析中,除CO组外,病变类型困难是缺氧的危险因素。结论:与传统NC相比,HFNC提供了充足的氧合和稳定的过程,在ESD镇静期间没有明显的不良事件。然而,需要谨慎避免与深度镇静和困难类型的病变相关的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology Medicine-Gastroenterology
自引率
2.40%
发文量
103
期刊介绍: Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.
期刊最新文献
Clarithromycin sustained-release tablet may be an improper therapy for the eradication of Helicobacter pylori. Enhancing self-management of patients with inflammatory bowel disease: the role of autonomy support in health goal pursuit. High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease. Turn over the new leaf of the treatment in peptic ulcer bleeding: a review of the literature. A nomogram incorporating ileal and anastomotic lesions separately to predict the long-term outcome of Crohn's disease after ileocolonic resection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1